Filing Details
- Accession Number:
- 0001209191-15-046711
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2015-05-26 16:36:12
- Reporting Period:
- 2015-05-21
- Filing Date:
- 2015-05-26
- Accepted Time:
- 2015-05-26 16:36:12
- Original Submission Date:
- 2015-05-01
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1142596 | Nuvasive Inc | NUVA | Surgical & Medical Instruments & Apparatus (3841) | 330768598 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1565985 | Russell Powers | 7475 Lusk Blvd. San Diego CA 92121 | Evp, International | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2015-05-21 | 2,410 | $48.09 | 75,088 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- On May 1, 2015, the Reporting Person reported a sale of shares to cover the exercise price of an underlying stock option. Due to broker error, the transaction was reversed and re-executed. Accordingly, the corresponding filing is hereby amended to reflect the final trade date and sale price. The sale was effected pursuant to a 10b5-1 Trading Plan adopted by the Reporting Person on March 10, 2015, which is intended to comply with Rule 10b5-1.
- Weighted average from two transactions with prices ranging from $48.0810 to $48.0947. Upon request by the Commission staff, the Issuer or a security holder of the Issuer, the Reporting Person will undertake to provide full information regarding the number of shares sold at each separate price.
- Shares directly held by the Reporting Person. The Reporting Person also holds conditional rights to receive or purchase (as appropriate) shares pursuant to previously disclosed Company equity awards.
Billionaire Hedge Funds
